CTOs on the Move

NuVasive

www.nuvasive.com

 
NuVasive® is an innovative medical device company focused on developing minimally disruptive surgical products and procedures for the spine. Our mission is to improve the lives of patients who suffer from debilitating back, neck, or leg pain by creating cutting-edge products and procedures that revolutionize spine surgery through focusing on Speed of Innovation®, Absolute Responsiveness®, and Superior Clinical Results. Through innovative technological advancements, NuVasive has successfully progressed major spine surgery to where many patients have experienced extraordinary results—they are often walking the same day of surgery, experiencing less blood loss, spending less time in the hospital, and going back to work ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.nuvasive.com
  • 7475 Lusk Boulevard
    San Diego, CA USA 92121
  • Phone: 858.909.1800

Executives

Name Title Contact Details
Aviva McPherron
 Chief Information Officer Profile
Ryan Donahoe
 Chief Technology Officer Profile
Prerna Mayor
 Director, IT Global Operational Systems Profile
Johnson Lai
 Chief Information Officer Profile

Similar Companies

PTS Diagnostics

PTS Diagnostics is an innovative point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company`s name represents the three pillars upon which it has built its long-term success: People, Technology and Service.

Carter Dental Lab

Carter Dental Lab is a Stuttgart, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tearlab

TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.

Bio-med Devices Inc

Bio-med Devices Inc is a Guilford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Philips Respironics, Inc.

Philips Respironics, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.